|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 35.18 USD | +4.61% |
|
-0.42% | +3.44% |
| 09-01 | UBS Initiates Assembly Biosciences at Buy With $52 Price Target | MT |
| 08-21 | Certain Common Stock of Assembly Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 21-AUG-2026. | CI |
| Market Cap | 716M 618M 581M 529M 996M 67.98B 1B 6.87B 2.67B 34.58B 2.69B 2.63B 115B | P/E 2026 * |
-302x | P/E 2027 * | -12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 630M 543M 511M 466M 875M 59.77B 880M 6.04B 2.35B 30.4B 2.36B 2.31B 101B | EV / Sales 2026 * |
9.93x | EV / Sales 2027 * | 17.1x |
| Free-Float |
72.34% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Assembly Biosciences, Inc.
| 1 day | +4.61% | ||
| 1 week | -0.42% | ||
| Current month | +4.61% | ||
| 1 month | +40.10% | ||
| 3 months | +30.68% | ||
| 6 months | +17.90% | ||
| Current year | +3.44% |
| 1 week | 32.92 |  | 35.9 |
| 1 month | 24.72 | | 37 |
| Current year | 21.8 | | 37 |
| 1 year | 20.23 | | 39.7 |
| 3 years | 7.69 | | 39.7 |
| 5 years | 7.69 | | 42.6 |
| 10 years | 7.69 | | 808.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 50 | 31/12/2022 |
| Director of Finance/CFO | - | 04/06/2025 | |
Katie Kitrinos
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Altig
CHM | Chairman | 70 | 03/06/2026 |
Susan Mahony
BRD | Director/Board Member | 61 | 13/12/2017 |
John McHutchison
BRD | Director/Board Member | 68 | 05/08/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/06/26 | Free | Director | 8,000 | 0.0514% | ||
| 04/06/26 | Free | Director | 8,000 | 0.0514% | ||
| 04/06/26 | Free | Director | 8,000 | 0.0514% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.61% | -0.42% | +42.43% | +199.15% | 685M | |
| +0.21% | -2.69% | +1.19% | +17.32% | 49.81B | |
| +2.09% | -0.71% | +452.73% | +498.77% | 44.06B | |
| -1.09% | -0.41% | +35.40% | +15.17% | 42.99B | |
| -0.26% | -4.71% | +17.19% | +71.67% | 40.88B | |
| -0.48% | -0.84% | +16.25% | +49.80% | 33.11B | |
| -1.06% | +2.87% | - | - | 17.27B | |
| -1.81% | -5.02% | +22.65% | +113.24% | 16.58B | |
| -1.35% | -3.40% | +10.13% | +26.34% | 14.63B | |
| -2.05% | -5.14% | +72.89% | +34.69% | 13.76B | |
| Average | -0.28% | -2.37% | +74.54% | +114.02% | 27.38B | |
| Weighted average by Cap. | -0.49% | -1.89% | +94.83% | +120.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.43M 54.71M 51.47M 46.89M 88.17M 6.02B 88.65M 608M 237M 3.06B 238M 233M 10.15B | 34.4M 29.67M 27.91M 25.43M 47.82M 3.26B 48.08M 330M 128M 1.66B 129M 126M 5.51B |
| Net income | 1.4M 1.21M 1.14M 1.04M 1.95M 133M 1.96M 13.46M 5.24M 67.75M 5.27M 5.15M 225M | -57.21M -49.35M -46.42M -42.29M -79.52M -5.43B -79.96M -549M -214M -2.76B -215M -210M -9.16B |
| Net Debt | -86.48M -74.6M -70.17M -63.93M -120M -8.21B -121M -830M -323M -4.18B -325M -318M -13.84B | -127M -109M -103M -93.79M -176M -12.04B -177M -1.22B -474M -6.13B -476M -466M -20.31B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$35.18 | +4.61% | 301,098 |
| 31/08/26 | US$33.63 | -1.29% | 235,972 |
| 28/08/26 | US$34.07 | -2.10% | 250,028 |
| 27/08/26 | US$34.80 | -1.75% | 192,123 |
| 26/08/26 | US$35.42 | +0.25% | 171,493 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ASMB Stock
Select your edition
All financial news and data tailored to specific country editions
